ANVS Annovis Bio, Inc.

Fundamentals / CIK 0001477845 / USD

Annovis Bio, Inc. reported $0 in revenue and a net loss of $51.72M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ANVS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$52.55MFY 2019 Net Income: -$991K2019FY 2020 Revenue: $0FY 2020 Net Income: -$5.46M2020FY 2021 Revenue: $0FY 2021 Net Income: -$14.49M2021FY 2022 Revenue: $0FY 2022 Net Income: -$25.33M2022FY 2023 Revenue: $0FY 2023 Net Income: -$56.20M2023FY 2024 Revenue: $0FY 2024 Net Income: -$24.59M2024FY 2025 Revenue: $0FY 2025 Net Income: -$28.85M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $0 $0 $0 $0 --
Research & Development $25.22M $20.00M $38.79M $16.52M $8.48M $3.05M $776K
Total Operating Expenses $29.70M $26.69M $45.04M $25.51M $14.54M $6.64M $1.61M
Operating Income -$29.70M -$26.69M -$45.04M -$25.51M -$14.54M -$6.64M -$1.61M
Interest Income $699K $332K $668K -- -- -- --
Income Before Tax -- -- -$56.20M -$25.33M -$14.49M -$5.46M -$991K
Income Tax Expense $0 -- -- -- -- -- --
Net Income -$28.85M -$24.59M -$56.20M -$25.33M -$14.49M -$5.46M -$991K
Basic EPS -$1.40 -$2.02 -$6.23 -$3.10 -$1.90 -$0.87 -$3.51
Diluted EPS -$1.40 -$2.31 -$6.23 -$3.10 -$1.90 -$0.87 -$3.51
Basic Shares Outstanding 20.6M 12.2M 9.0M 8.2M 7.6M 6.3M 282.6K
Diluted Shares Outstanding 20.6M 12.2M 9.0M 8.2M 7.6M 6.3M 282.6K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $15.78M $12.01M $16.72M $8.75M $6.29M $5.16M $5.01M $5.00M
Total Operating Expenses $16.97M $14.38M $18.01M $9.71M $7.43M $6.27M $6.28M $6.73M
Operating Income -$16.97M -$14.38M -$18.01M -$9.71M -$7.43M -$6.27M -$6.28M -$6.73M
Interest Income $85K $160K $138K $168K $152K $191K $188K $126K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 --
Net Income -$9.46M -$14.82M -$17.61M -$9.83M -$7.26M -$6.22M -$5.54M -$5.86M
Basic EPS -$0.22 -$0.40 -$0.63 -- -$0.37 -$0.32 -$0.32 --
Diluted EPS -$0.22 -$0.40 -$0.63 -- -$0.37 -$0.32 -$0.32 --
Basic Shares Outstanding 42.6M 37.5M 27.8M -- 19.7M 19.5M 17.4M --
Diluted Shares Outstanding 42.6M 37.5M 27.8M -- 19.7M 19.5M 17.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Sep 30 Jun 30 Mar 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $19.53M $10.55M $5.75M $28.38M $31.99M $35.97M $42.67M $45.69M $8.07M $1.9K
Cash & Short-Term Investments $19.53M $10.55M $5.75M $28.38M $31.99M $35.97M $42.67M $45.69M $8.07M $1.9K
Total Current Assets -- -- $10.21M $36.02M $37.12M $39.97M $44.10M $46.00M $8.12M $748K
Total Non-Current Assets -- -- $0 $0 $0 $0 $0 $0 $0 $370K
Total Assets $21.08M $13.93M $10.21M $36.02M $37.12M $39.97M $44.10M $46.00M $8.12M $1.12M
Accounts Payable $2.59M $2.31M $1.29M $3.96M $1.85M $902K $929K $688K $342K $1.23M
Total Current Liabilities $3.64M $3.88M $4.28M $7.70M $2.53M $1.30M $1.40M $1.51M $578K $2.01M
Total Non-Current Liabilities $595K $737K $13.68M $0 $0 $0 $0 $0 $0 $606K
Total Liabilities $4.23M $4.62M $17.96M $7.70M $2.53M $1.30M $1.40M $1.51M $578K $2.62M
Common Stock $2.7K $1.4K $1.1K $816 $816 $816 $816 $810 $689 $28
Retained Earnings -$163.7M -$134.8M -$110.3M -$54.05M -$46.33M -$39.90M -$33.96M -$28.73M -$14.24M -$8.78M
Total Stockholders' Equity $16.85M $9.31M -$7.75M $28.32M $34.59M $38.67M $42.70M $44.49M $7.54M -$8.58M
Total Equity $16.85M $9.31M -$7.75M $28.32M $34.59M $38.67M $42.70M $44.49M $7.54M -$8.58M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $2.82M $18.73M $14.22M $19.53M $15.29M $17.13M $22.24M $10.55M
Cash & Short-Term Investments $2.82M $18.73M $14.22M $19.53M $15.29M $17.13M $22.24M $10.55M
Total Assets $5.50M $22.04M $16.24M $21.08M $17.19M $21.45M $26.74M $13.93M
Accounts Payable $3.05M $3.33M $5.28M $2.59M $2.11M $974K $1.37M $2.31M
Total Current Liabilities $6.26M $6.36M $12.79M $3.64M $3.73M $2.81M $2.50M $3.88M
Total Non-Current Liabilities $12.47M $19.93M $327K $595K $299K $319K $179K $737K
Total Liabilities $18.74M $26.29M $13.12M $4.23M $4.03M $3.12M $2.68M $4.62M
Common Stock $4.3K $4.3K $2.9K $2.7K $2.0K $1.9K $1.9K $1.4K
Retained Earnings -$205.6M -$196.1M -$181.3M -$163.7M -$153.9M -$146.6M -$140.4M -$134.8M
Total Stockholders' Equity -$13.23M -$4.25M $3.13M $16.85M $13.16M $18.33M $24.05M $9.31M
Total Equity -$13.23M -$4.25M $3.13M $16.85M $13.16M $18.33M $24.05M $9.31M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$28.85M -$24.59M -$56.20M -$25.33M -$14.49M -$5.46M -$991K
Stock-Based Compensation $1.80M $3.84M $4.63M $9.15M $4.70M $1.86M $8.5K
Change in Payables $285K $1.01M -$2.67M $3.27M $346K -$696K $969K
Operating Cash Flow -$25.62M -$21.89M -$39.97M -$17.31M -$9.13M -$3.97M -$477K
Common Stock Issued -- $18.67M $16.89M -- $46.65M $12.03M --
Financing Cash Flow $34.60M $26.69M $17.34M $4.6K $46.74M $12.04M $443K
Net Change in Cash $8.98M $4.80M -$22.62M -$17.31M $37.61M $8.07M -$33K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$9.46M -$14.82M -$17.61M -$9.83M -$7.26M -$6.22M -$5.54M -$5.86M
Stock-Based Compensation $355K $1.61M $183K $357K $445K $497K $500K $1.48M
Change in Payables -$274K -$1.95M $2.69M $478K $1.14M -$396K -$936K -$1.79M
Operating Cash Flow -$16.04M -$21.91M -$9.01M -$8.93M -$3.49M -$5.11M -$8.10M -$8.29M
Common Stock Issued -- -- -- -- -- -- -- $6.20M
Financing Cash Flow $128K $26.42M $3.70M $13.17M $1.64M $0 $19.78M $6.20M
Net Change in Cash -$15.91M $4.51M -$5.31M $4.25M -$1.84M -$5.11M $11.68M -$2.08M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -171.2% -264.2% -- -89.4% -32.6% -72.4% --
Return on Assets (ROA) -136.9% -176.6% -550.6% -70.3% -31.5% -67.3% -88.7%
Current Ratio -- -- 2.39x 4.68x 30.54x 14.04x 0.37x
Quick Ratio 5.37x 2.72x 1.34x 3.69x 30.33x 13.96x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -1309.1% -171.2% -189.1% -165.1% -120.8% -264.2%
Return on Assets (ROA) -939.8% -224.7% -251.9% -136.9% -144.8% -141.0% -108.7% -176.6%
Quick Ratio 0.45x 2.95x 1.11x 5.37x 4.09x 6.11x 8.88x 2.72x
Source: SEC EDGAR CompanyFacts (CIK 0001477845) · from March 31, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal